Authors





Bernard J. Tyson

Latest:

Moving From Healthcare to Health

Focusing on quality and quality measurements has the potential to reduce costs, increase quality, and deliver more value to patients, consumers, and customers.


James D. Ralston, MD, MPH

Latest:

Racial/Ethnic Variation in Devices Used to Access Patient Portals

The study examined the variation in devices used (desktop/laptop computer, mobile device, or both device types) by patients of different racial/ethnic backgrounds to access the online patient portal.



Peter Fagan, PhD

Latest:

Annual Diabetic Eye Examinations in a Managed Care Medicaid Population

We assessed challenges and barriers to annual diabetic eye examinations for a managed care Medicaid population and make recommendations to improve population-level screening.


Patricia White, PhD

Latest:

Psychological Family Intervention for Poorly Controlled Type 2 Diabetes

A family-based intervention targeting negative and/or inaccurate illness perceptions in patients with poorly controlled type 2 diabetes was effective in improving glycemic control.


Alicia L. Cooper, MPH, PhD

Latest:

Predictors of High-Risk Prescribing Among Elderly Medicare Advantage Beneficiaries

This study examines patterns of high-risk prescribing in the elderly Medicare Advantage population and demonstrates that the practice varies widely by geography and drug class.


Renuka Gupte, PhD

Latest:

Accountable Care Organizations and Patient-Centered Medical Homes: Health Expenditures and Health Services

This study compares health care costs and health services utilization patterns of patients receiving care in accountable care organization (ACO), patient-centered medical home (PCMH), hybrid (ACO + PCMH), and standard (neither ACO/PCMH) facilities.


Glenn Davies, DrPH

Latest:

Cost-effectiveness of Intensification With SGLT2 Inhibitors for Type 2 Diabetes

Adding a sodium-glucose co-transporter 2 (SGLT2) inhibitor dominated switching to a glucagon-like peptide 1 receptor agonist over the lifetimes of patients with type 2 diabetes not at glycated hemoglobin A1c target after treatment with metformin plus a dipeptidyl peptidase-4 inhibitor.



Dalit Baranoff, PhD

Latest:

Comparing Apples With Oranges: Administrative Expenses and Finances in Medicare Systems

In the debate of administrative expenses for public and private Medicare, we show incompatibility and extend the analysis to income, benefits, and loss ratio comparisons.


James A. Duncan, MD

Latest:

The Vermedx® Diabetes Information System Reduces Healthcare Utilization

This analysis of paid claims from a physician hospital organization demonstrates that the Vermedx Diabetes Information System improves healthcare costs for adults with diabetes.



Marieke Spreeuwenberg, PhD

Latest:

Toward Tailored Disease Management for Type 2 Diabetes

The heterogeneous nature of care processes and patients should be taken into account in both the design and evaluation of disease management programs for diabetes.


Arif Gilani

Latest:

A Retrospective on the Oncology Care Model

Flatiron Health recently conducted a retrospective review of the Oncology Care Model, discovering what's working, what isn't, and what this could mean for the future.



Jingyuan Qian, MPP

Latest:

Value-Based Arrangements May Be More Prevalent Than Assumed

We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.


Sandra McNaney, BS

Latest:

CKD Quality Improvement Intervention With PCMH Integration: Health Plan Results

A scalable chronic kidney disease (CKD) quality improvement intervention demonstrated feasibility, decreased hospitalization, and reduced costs. These preliminary results support innovation in CKD by commercial health plans.



David Brody, MD

Latest:

Postdischarge Telephone Calls by Hospitalists as a Transitional Care Strategy

Treating hospitalists effectively identify and efficiently address early postdischarge problems through a single, brief telephone encounter.



Lane Burgette, PhD

Latest:

Are Value-Based Incentives Driving Behavior Change to Improve Value?

Value-based payment is promoting care delivery transformation among California physician organizations, although the initial focus has been on controlling hospital costs and redesigning primary care.



Dina Appleby, MS

Latest:

A Randomized Controlled Trial of Negative Co-Payments: The CHORD Trial

This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.


Brandy D. McGinnis, PharmD

Latest:

Statin Adherence and Mortality in Patients Enrolled in a Secondary Prevention Program

Enrollment in a secondary disease prevention program can have a significant impact on statin adherence and subsequent clinical outcomes.


S. Patrick Hammond, MHA

Latest:

A Model for Delivering Population Health Across the Care Continuum

The Population Health Care Delivery Model presents delivery systems with a framework for developing, piloting, and implementing population health programs across the continuum of care.


Kari L. Olson, PharmD

Latest:

Systolic Blood Pressure Control After Participation in a Hypertension Intervention Study

Systolic blood pressure control was not maintained in a large proportion of patients after the end of participation in a hypertension intervention study.


Dawn Holcombe, FACMPE, MBA

Latest:

Oncology Management Programs for Payers and Physicians

Evaluating current models and diagnosing successful strategies for payers and physicians.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo